Kaitlyn Mccann

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Less frequent clinical and viral load assessments during COVID did not increase virological failure.

Less frequent clinical and viral load assessments during COVID did not increase virological failure.

Journal: International journal of STD & AIDS

Published: May 21, 2026

Low CD4 counts predict excessive weight gains during first-line treatment for HIV.

Low CD4 counts predict excessive weight gains during first-line treatment for HIV.

Journal: The Journal of antimicrobial chemotherapy

Published: January 15, 2024

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens.

Journal: Open forum infectious diseases

Published: August 21, 2023

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.

Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.

Journal: Frontiers in reproductive health

Published: December 29, 2022

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG.

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 12, 2022

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.

Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.

Journal: Open forum infectious diseases

Published: February 11, 2022

Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).

Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).

Journal: The Journal of antimicrobial chemotherapy

Published: August 20, 2021

RETRACTED: Expression of Concern: "Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection".

RETRACTED: Expression of Concern: "Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection".

Journal: Open forum infectious diseases

Published: August 19, 2021

Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes.

Implications of weight gain with newer anti-retrovirals: 10-year predictions of cardiovascular disease and diabetes.

Journal: AIDS (London, England)

Published: April 30, 2021

Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.

Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.

Journal: Open forum infectious diseases

Published: January 20, 2021

Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials.

Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials.

Journal: AIDS (London, England)

Published: October 13, 2020

Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure: Updated Data from the ADVANCE Trial.

Participants on Dolutegravir Resuppress Human Immunodeficiency Virus RNA After Virologic Failure: Updated Data from the ADVANCE Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 02, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026